COMMUNIQUÉS West-GlobeNewswire

TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601
02/11/2017
COMMUNIQUÉ DE PRESSE TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601 Louvain (BELGIQUE) - 2 novembre 2017, 07h. CET - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]
Targovax ASA: Third quarter 2017 results
02/11/2017
Oslo, Norway, 2 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its third quarter 2017 results. A meeting for [...]
Orion Corporation: Managers' transactions - Hilpi Rautelin
01/11/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 1 st of November 2017 at 22.15 EET Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse [...]
Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference
01/11/2017
DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]
Medtronic Unveils Strong Early Outcomes for the Intrepid(TM) Transcatheter Mitral Valve Replacement (TMVR) System
01/11/2017
First Report Investigation at TCT Published in JACC Shows Substantial Mitral Valve Regurgitation Reductions and Versatility of Dual-Stent Design DUBLIN and DENVER - November 1, 2017 - Medtronic plc (NYSE:MDT) today [...]
Independent Study Shows New Data on Shortened DAPT in STEMI Patients with Medtronic Resolute Integrity Drug-Eluting Stent
01/11/2017
DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI [...]
Shire plc : Director/PDMR Shareholding
01/11/2017
Director/PDMR Shareholding November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH
01/11/2017
Heidelberg, Germany, November 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that the [...]
uniQure Announces Presentations at the 59th American Society of Hematology (ASH) Annual Meeting
01/11/2017
~ New Nonclinical Data on AMT-061 to be Presented Saturday, December 9, 2017 ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy [...]
Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease
01/11/2017
Primary results of pivotal Kymriah TM Phase II JULIET study in relapsed/refractory DLBCL Post-hoc sub-analysis of crizanlizumab (SEG101, formerly SelG1) SUSTAIN trial evaluating time to first sickle cell pain crisis [...]
Inivata Announces Strategic Partnership with West Cancer Center
01/11/2017
Inivata Announces Strategic Partnership with West Cancer Center West Cancer Center joins the Inivata Knowledge Accumulation Network (IKAN) Research Triangle Park, NC and Cambridge, UK, November 1, 2017 -- Inivata , a [...]
Align Technology Ongoing Support of Orthodontic and Dental Research
01/11/2017
2018 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, CA--(Marketwired - November 01, 2017) - Align Technology, Inc. (NASDAQ: ALGN ) today announced the opening of its 2018 Research Award [...]
Shire plc : Total voting rights
01/11/2017
Total Voting Rights November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017
01/11/2017
Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital Conference Call to Review Results to be [...]
uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress
01/11/2017
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines
01/11/2017
RIZAPORT ® is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines A Prescription Drug User Fee Act (PDUFA) date is expected to be set by the FDA for the first half of 2018, if [...]
Enzymatica AB: Sales soar in third quarter
01/11/2017
Enzymatica Interim Report January-September 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017
01/11/2017
Reported sales increased by 2% to DKK 83.7 billion (3% in local currencies) Sales within diabetes and obesity care increased by 7% to DKK 69.7 billion (8% in local currencies). Sales of Tresiba ® increased by 117% to [...]
uniQure Announces Multiple Company Presentations at Upcoming November Conferences
31/10/2017
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]

Pages